Title:
URONIC ACID COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2019/080842
Kind Code:
A1
Abstract:
Provided in the present invention is a compound of formula (I) or pharmaceutically acceptable salt, solvate or metabolite thereof, which can be used for treating and/or preventing ischemia-reperfusion injury and related diseases, acute respiratory distress syndrome and related diseases, acute lung injury and related diseases, pathological cardiac hypertrophy and related diseases, and/or fatty liver disease and related diseases.
Inventors:
LI HONGLIANG (CN)
ZHANG XIAOJING (CN)
ZHANG XIAOJING (CN)
Application Number:
PCT/CN2018/111487
Publication Date:
May 02, 2019
Filing Date:
October 23, 2018
Export Citation:
Assignee:
UNIV WUHAN (CN)
International Classes:
C07D277/82; A61K31/63; A61P9/10
Domestic Patent References:
| WO2015054662A1 | 2015-04-16 |
Other References:
DIANE K. LUCI ET AL.: "Synthesis and Structure-Activity Relationship Studies of 4-((2-Hydroxy-3-methoxybenzyl)amino)benzenesulfonamide Derivatives as Po- tent and Selective Inhibitors of 12-Lipoxygenase", JOURNAL OF MEDICINAL CHEMISTRY,, vol. 57, no. 2, 6 January 2014 (2014-01-06), pages 495 - 506, XPP002791671
ZHU, Y. ET AL, JOURNAL OF HARBIN MEDICAL UNIVERSITY, vol. 51, no. 2, 30 April 2017 (2017-04-30), pages 100
ZHU, Y. ET AL, JOURNAL OF HARBIN MEDICAL UNIVERSITY, vol. 51, no. 2, 30 April 2017 (2017-04-30), pages 100
Attorney, Agent or Firm:
CCPIT PATENT AND TRADEMARK LAW OFFICE (CN)
Download PDF: